Executive Summary: Global AI Protein Design Market

2.1. Research Objective

2.2. Product Overview

2.3. Market Segmentation

2.4. Qualitative Research
2.4.1. Primary & Secondary Sources

2.5. Quantitative Research
2.5.1. Primary & Secondary Sources

2.6. Breakdown of Primary Research Respondents, By Region

2.7. Assumption for Study

2.8. Market Size Estimation

2.9. Data Triangulation

3.1. Industry Value Chain Analysis
3.1.1. Protein-Sequence, Structural & Genomic Data Providers
3.1.2. Foundation Model & Generative-Biology Algorithm Developers
3.1.3. Cloud / GPU Compute & AI Protein-Design Platform Vendors
3.1.4. Wet-Lab Validation, CRO & Synthesis Partners
3.1.5. End Users (Biopharma, Biotech Startups, Academic & Research, CROs)

3.2. Industry Outlook
3.2.1. Overview of the Global AI Protein Design & Generative-Biology Industry
3.2.2. De Novo Design, Structure Prediction & Clinical-Pipeline Translation
3.2.3. Biosecurity Screening, Data Quality & Model-Validation Considerations

3.3. PESTLE Analysis

3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitutes
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition

3.5. Market Growth and Outlook
3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
3.5.2. Price Trend Analysis, By Offering

4.1. Competition Dashboard
4.1.1. Market Concentration Rate
4.1.2. Company Market Share Analysis (Value %), 2025
4.1.3. Competitor Mapping & Benchmarking

5.1. Market Dynamics and Trends
5.1.1. Growth Drivers
5.1.2. Restraints
5.1.3. Opportunity
5.1.4. Key Trends

5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
5.2.1. By Offering
5.2.1.1. Key Insights
5.2.1.1.1. Software/Platforms & Models
5.2.1.1.2. Services
5.2.2. By Technology
5.2.2.1. Key Insights
5.2.2.1.1. Generative AI Models
5.2.2.1.2. Deep-Learning Structure Prediction
5.2.2.1.3. Reinforcement Learning
5.2.2.1.4. Hybrid AI-Physics
5.2.3. By Application
5.2.3.1. Key Insights
5.2.3.1.1. Therapeutics
5.2.3.1.1.1. Antibody Design
5.2.3.1.1.2. Miniprotein/Binder Design
5.2.3.1.2. Enzyme Engineering
5.2.3.1.3. Cell & Gene Therapy Design
5.2.3.1.4. Vaccine Antigen Design
5.2.3.1.5. Industrial Proteins
5.2.4. By Deployment
5.2.4.1. Key Insights
5.2.4.1.1. Cloud/API
5.2.4.1.2. On-Premises
5.2.5. By End User
5.2.5.1. Key Insights
5.2.5.1.1. Biopharma
5.2.5.1.2. Biotech Startups
5.2.5.1.3. Academic & Research
5.2.5.1.4. CROs
5.2.6. By Region
5.2.6.1. Key Insights
5.2.6.1.1. North America
5.2.6.1.1.1. The U.S.
5.2.6.1.1.2. Canada
5.2.6.1.1.3. Mexico
5.2.6.1.2. Europe
5.2.6.1.2.1. Western Europe
5.2.6.1.2.1.1. The UK
5.2.6.1.2.1.2. Germany
5.2.6.1.2.1.3. France
5.2.6.1.2.1.4. Italy
5.2.6.1.2.1.5. Spain
5.2.6.1.2.1.6. Rest of Western Europe
5.2.6.1.2.2. Eastern Europe
5.2.6.1.2.2.1. Poland
5.2.6.1.2.2.2. Russia
5.2.6.1.2.2.3. Rest of Eastern Europe
5.2.6.1.3. Asia Pacific
5.2.6.1.3.1. China
5.2.6.1.3.2. India
5.2.6.1.3.3. Japan
5.2.6.1.3.4. Australia & New Zealand
5.2.6.1.3.5. South Korea
5.2.6.1.3.6. ASEAN
5.2.6.1.3.7. Rest of Asia Pacific
5.2.6.1.4. Middle East & Africa (MEA)
5.2.6.1.4.1. Saudi Arabia
5.2.6.1.4.2. South Africa
5.2.6.1.4.3. UAE
5.2.6.1.4.4. Rest of MEA
5.2.6.1.5. South America
5.2.6.1.5.1. Argentina
5.2.6.1.5.2. Brazil
5.2.6.1.5.3. Rest of South America

6.1. Market Dynamics and Trends
6.1.1. Growth Drivers
6.1.2. Restraints
6.1.3. Opportunity
6.1.4. Key Trends

6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
6.2.1. Key Insights
6.2.1.1. By Offering
6.2.1.2. By Technology
6.2.1.3. By Application
6.2.1.4. By Deployment
6.2.1.5. By End User
6.2.1.6. By Country

7.1. Market Dynamics and Trends
7.1.1. Growth Drivers
7.1.2. Restraints
7.1.3. Opportunity
7.1.4. Key Trends

7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
7.2.1. Key Insights
7.2.1.1. By Offering
7.2.1.2. By Technology
7.2.1.3. By Application
7.2.1.4. By Deployment
7.2.1.5. By End User
7.2.1.6. By Country

8.1. Market Dynamics and Trends
8.1.1. Growth Drivers
8.1.2. Restraints
8.1.3. Opportunity
8.1.4. Key Trends

8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
8.2.1. Key Insights
8.2.1.1. By Offering
8.2.1.2. By Technology
8.2.1.3. By Application
8.2.1.4. By Deployment
8.2.1.5. By End User
8.2.1.6. By Country

9.1. Market Dynamics and Trends
9.1.1. Growth Drivers
9.1.2. Restraints
9.1.3. Opportunity
9.1.4. Key Trends

9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
9.2.1. Key Insights
9.2.1.1. By Offering
9.2.1.2. By Technology
9.2.1.3. By Application
9.2.1.4. By Deployment
9.2.1.5. By End User
9.2.1.6. By Country

10.1. Market Dynamics and Trends
10.1.1. Growth Drivers
10.1.2. Restraints
10.1.3. Opportunity
10.1.4. Key Trends

10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
10.2.1. Key Insights
10.2.1.1. By Offering
10.2.1.2. By Technology
10.2.1.3. By Application
10.2.1.4. By Deployment
10.2.1.5. By End User
10.2.1.6. By Country

11.1. DeepMind Technologies Limited
11.2. Generate: Biomedicines
11.3. Arzade Corp.
11.4. Insilico Medicine
11.5. Cradle
11.6. Profluent
11.7. A-Alpha Bio, inc.
11.8. Schrodinger, Inc.
11.9. DenevAI Biotrech
11.10. Symbio Technologies
11.11. Other Prominent Players

12.1. List of Secondary Sources
12.2. Key Country Markets- Macro Economic Outlook/Indicators